NICE will review whether new Alzheimer’s drugs should be offered on the NHS after an appeal found their wider impact...
A stem cell therapy improved mobility in older adults with age-related frailty after nine months in a phase 2b trial, compared with placebo. Frailty is a...
Global market to hit US$740bn in 2026, longevity needs lifts? ‘little brain’s’ big role, ageing ethics questioned…and more IRISH insight and analysis company Research and Markets...
Sleep apnoea costs the UK and US economies more than £137bn a year, with researchers calling for workplace screening and earlier treatment. The condition causes repeated...
Nyra health has raised €20m to scale its digital neurotherapy platform for neurological rehabilitation, targeting conditions such as stroke and dementia. The Series A funding will...
Centenarians’ blood contains 37 proteins linked to slower ageing, with profiles closer to younger adults than to octogenarians, according to new research. In Switzerland, around 0.02...
Despite having its application for a new, daily Alzheimer’s pill rejected by Europe’s regulators the CEO of US drug company Anavex Life Sciences is appealing this...
